PeerVoice Immunology & Infectious Disease Audio

By PeerVoice

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

  1. 1.
    "Novel Approaches to Personalized Patient Care in Still's Disease"
    58:11
  2. 2.
    Living With Multidrug-Resistant HIV: What Clinicians Need to Know
    28:10
  3. 3.
    Non-Oncotic Methods for Managing the Milieu of Decompensated Liver Cirrhosis
    18:12
  4. 4.
    Clinical Developments in Managing Autoinflammatory Diseases
    30:22
  5. 5.
    Therapy for COVID-19: Management Strategies and Clinical Rationale
    29:48
  6. 6.
    Going the Distance in HIV: Simplifying ART at Every Stage
    24:03
  7. 7.
    Simplifying Screening for Immunodeficiencies: A Practical Strategy Using Calculated Serum Globulin
    28:13
  8. 8.
    Unmet Needs in Familial Mediterranean Fever (FMF): Real-Life Data, the Patient Perspective, and the Role of Anti–IL-1 Therapy
    59:05
  1. 9.
    GP Empowerment: Eliminating HCV From the Front Line
    29:21
  2. 10.
    If You Suspect, Test! The Important First Steps to Preventing the Devastating Consequences of Hepatitis
    19:48
  3. 11.
    Can Long-Acting Injectables Make a Difference in HIV?
    25:43
  4. 12.
    Optimising HBV Treatment Outcomes Whilst We Hunt for a Cure
    17:55
  5. 13.
    Opportunistic Invasive Fungal Infections: Proactive Diagnosis of Patients at Risk
    23:13
  6. 14.
    Practical Strategies in Optimising Subcutaneous Immunoglobulin Replacement Therapy
    1:01:13
  7. 15.
    Managing Complexity in Atopic Dermatitis: What Can We Learn From the Real World?
    27:29
  8. 16.
    Modern Management of Chronic Kidney Disease: A Look to the Future
    15:04
  9. 17.
    Unmet Needs in Familial Mediterranean Fever (FMF): Real-Life Data, the Patient Perspective, and the Role of Anti–IL-1 Therapy
    59:06
  10. 18.
    Practice-Changing Perspectives in CMV: Managing the Burden in HSCT and SOT
    25:45
  11. 19.
    Transforming the Treatment of Acute Hepatic Porphyria
    17:34
  12. 20.
    Hidden in Plain Sight: Uncovering Truncal Acne
    13:03
  13. 21.
    When to Consider Long-Term Prophylaxis for Hereditary Angioedema
    23:24
  14. 22.
    Identifying Barriers to and Developing Opportunities for Rotavirus Vaccination
    17:53
  15. 23.
    Weighing Evidence and Perspectives on JAK Inhibitors in Psoriatic Arthritis: Can We Do More for Patients?
    18:31
  16. 24.
    Patient Scenarios in Rheumatoid Arthritis: Optimising Remission With JAK Inhibitors
    16:56
  17. 25.
    "Case Studies in Locally Advanced and Metastatic CSCC: Integrating Immunotherapy Into Current Treatment Paradigms"
    20:12
  18. 26.
    Wake Up and Smell the Coffee: Kicking Into Play Novel Treatment Options for Nasal Polyposis
    20:47
  19. 27.
    IL-6 Receptor Inhibition in RA: New Perspectives in Optimal Patient Care
    1:13:39
  20. 28.
    Teaming Up to Improve Outcomes in Immunology: The Importance of an Integrated Approach to Disease Control
    19:13
  21. 29.
    Elimination of Hepatitis C: Simple Changes for Comprehensive Results
    19:59
  22. 30.
    Targeting Remission in Auto-Inflammatory Diseases With Anti─IL-1β
    46:04
  23. 31.
    Imagining a World Without Hepatitis C Virus: A Call to Action
    10:03
  24. 32.
    Learning From the Literature: The Latest Evidence on JAK Inhibitors for RA
    16:27
  25. 33.
    Do You Know JAK? Updates From Chicago on Rheumatoid Arthritis Management
    18:59
  26. 34.
    Wheeze, Asthma, and Lung Function: Latest Insights on the Long-Term Impact of Severe RSV in Infancy
    16:44
  27. 35.
    Management of Autoinflammatory Recurrent Fever Syndromes: What Recent Data Results Mean for Clinical Practice
    17:52
  28. 36.
    How a New Understanding of Severe Asthma Is Changing Treatment Paradigms
    19:37
  29. 37.
    Treatment Initiation and Persistence in HIV: The Case for Optimisation in the Real World
    15:45
  30. 38.
    Navigating the Road to Psoriasis Control in Women: Strategies to Optimise the Reproductive Journey
    1:06:51
  31. 39.
    Endotyping Severe Asthma: For Which Patients and Why?
    16:41
  32. 40.
    Strategies for Optimizing Herpes Zoster Immunization in Canadian Practice
    10:46
  33. 41.
    Forging a Path to RA Treatment: Exploring the Potential for IL-6 Inhibitors
    16:23
  34. 42.
    Newer Targeted Therapies for Rheumatoid Arthritis: Weighing the Pros and Cons
    14:50
  35. 43.
    Conversations on Steps to Biologic Therapy for Atopic Dermatitis: Patient and Dermatologist Insights for European Practice
    17:51
  36. 44.
    Expert Perspectives on Managing Complex Patients With Spondyloarthritis
    21:29
  37. 45.
    Protecting Adolescents and Adults From Vaccine Preventable Bacterial Diseases: A Look at Serogroup B Meningococcal Disease and Pneumococcal Diseases
    16:54
  38. 46.
    Getting Under the Skin in Atopic Dermatitis: Evolving Treatment Approaches
    18:00
  39. 47.
    Treating Rheumatoid Arthritis and Spondyloarthritis to Target: What Are We Missing in Clinical Practice?
    21:27
  40. 48.
    Von der Krankheitsentstehung zu klinischen Strategien für autoinflammatorische und Autoimmunerkrankungen: Welche Rolle spielen Interleukine?
    40:51
  41. 49.
    Enthesitis in Psoriatic Arthritis and Spondyloarthritis: Targeting Pathophysiologic Mechanisms to Optimise Patient Management
    21:05
  42. 50.
    Defining the Optimal Respiratory Syncytial Virus Infection Management Strategy: Applying Health Economics to Improve Patient Outcomes
    19:07

Listen to PeerVoice Immunology & Infectious Disease Audio now.

Listen to PeerVoice Immunology & Infectious Disease Audio in full in the Spotify app